Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Malignant Melanoma

  Free Subscription


1 Am J Ophthalmol
3 Ann Surg Oncol
1 BMC Cancer
1 Br J Dermatol
1 Cancer
1 J Am Acad Dermatol
1 J Clin Oncol
1 J Invest Dermatol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Ophthalmol

  1. MATHIS T, Hofverberg P, Caujolle JP, Herault J, et al
    Occurrence of phosphenes in patients undergoing proton beam therapy for ocular tumor.
    Am J Ophthalmol. 2018 May 10. pii: S0002-9394(18)30216.
    PubMed     Text format     Abstract available

    Ann Surg Oncol

  2. MASOUD SJ, Hu JB, Beasley GM, Stewart JH 4th, et al
    Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size.
    Ann Surg Oncol. 2019 Aug 14. pii: 10.1245/s10434-019-07691.
    PubMed     Text format     Abstract available

  3. NIJHUIS AAG, Santos Filho IDAO, Holtkamp LHJ, Uren RF, et al
    Sentinel Node Biopsy for Melanoma Patients with a Local Recurrence or In-Transit Metastasis.
    Ann Surg Oncol. 2019 Aug 12. pii: 10.1245/s10434-019-07699.
    PubMed     Text format     Abstract available

  4. BLOEMENDAL M, van Willigen WW, Bol KF, de Wilt JHW, et al
    ASO Author Reflections: Frequent Relapses Prior to the Start of Adjuvant Therapy in Stage IIIB/C Melanoma.
    Ann Surg Oncol. 2019 Aug 8. pii: 10.1245/s10434-019-07665.
    PubMed     Text format    

    BMC Cancer

  5. LEE J, Lee SJ, Kim K, Kim ST, et al
    Comprehensive molecular and clinical characterization of Asian melanoma patients treated with anti-PD-1 antibody.
    BMC Cancer. 2019;19:805.
    PubMed     Text format     Abstract available

    Br J Dermatol

  6. SHEEN YS, Tan KT, Tse KP, Liao YH, et al
    Genetic Alterations in Primary Melanoma in Taiwan.
    Br J Dermatol. 2019 Aug 13. doi: 10.1111/bjd.18425.
    PubMed     Text format     Abstract available


  7. SCHVARTSMAN G, Ma J, Bassett RL Jr, Haydu LE, et al
    Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
    Cancer. 2019 Aug 9. doi: 10.1002/cncr.32454.
    PubMed     Text format     Abstract available

    J Am Acad Dermatol

  8. VAREDI A, Gardner LJ, Kim CC, Chu EY, et al
    Use of new molecular tests for melanoma by pigmented lesion experts.
    J Am Acad Dermatol. 2019 Aug 12. pii: S0190-9622(19)32569.
    PubMed     Text format    

    J Clin Oncol

  9. SHENG X, Yan X, Chi Z, Si L, et al
    Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G4 Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial.
    J Clin Oncol. 2019 Aug 12:JCO1900210. doi: 10.1200/JCO.19.00210.
    PubMed     Text format     Abstract available

    J Invest Dermatol

  10. ZHOU S, Liang Y, Zhang X, Liao L, et al
    SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.
    J Invest Dermatol. 2019 Aug 8. pii: S0022-202X(19)32683.
    PubMed     Text format     Abstract available


  11. CALIFF RM, Shinkai K
    Filling in the Evidence About Sunscreen.
    JAMA. 2019;321:2077-2079.
    PubMed     Text format    

    PLoS One

  12. VALLEE A, Denis-Musquer M, Herbreteau G, Theoleyre S, et al
    Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay.
    PLoS One. 2019;14:e0221123.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.